Search Results - christopher+dalloul

1 Results Sort By:
c‑Abl Modulators for Neurodegenerative Disease Treatment
Application Small‑molecule c‑Abl inhibitors designed to treat neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Key Benefits Targets c‑Abl, a key regulator linked to neurodegeneration, oxidative stress, and loss of dopaminergic neurons. Provides new small‑molecule scaffolds with potential for improved safety profiles...
Published: 3/2/2026   |   Inventor(s): Thomas Kaiser, Zackery Dentmon, Christopher Dalloul, Dennis Liotta
Keywords(s): Drug Target Identification, Neurology and Pain Treatments, Rare and Orphan Disease Treatments, Small Molecule, Therapeutics
Category(s): TechPub Algolia > Drug Discovery